Research study · The Neuroscientist · 2023
Do Endocannabinoids Cause the Runner’s High? Evidence and Open Questions
Verified on PubMed Systematic review or meta-analysis
A 2023 systematic review in The Neuroscientist tested endocannabinoids in running. 14 of 17 studies detected an increase in endocannabinoids after acute exercise. This review clarifies that current evidence does not yet support using endocannabinoid levels as a reliable explanation for exercise-induced euphoria in humans.
In plain language
Study overview
Clinicians should consider the potential role of endocannabinoids in exercise-induced euphoria, but further research is needed to establish definitive links and mechanisms.
Findings
14 of 17 studies detected an increase in endocannabinoids after acute exercise. Four articles described a decrease in endocannabinoids after long-term endurance exercise. Reliable proof of the involvement of endocannabinoids in the runner's high in humans has not yet been achieved.
The deeper readScientific analysis
The runner's high is an ephemeral feeling some humans experience during and after endurance exercise. Recent evidence in mice suggests that a runner's high depends on the release of endocannabinoids (eCBs) during exercise. However, little is known under what circumstances eCBs are released during exercise in humans. This systematic review sampled all data from clinical trials in humans on eCB levels following exercise from the discovery of eCBs until April 20, 2021. PubMed/NCBI, Ovid MEDLINE, and Cochrane library were searched systematically and reviewed following the PRISMA guidelines. From 278 records, 21 met the inclusion criteria. After acute exercise, 14 of 17 studies detected an increase in eCBs. In contrast, after a period of long-term endurance exercise, four articles described a decrease in eCBs. Even though several studies demonstrated an association between eCB levels and features of the runner's high, reliable proof of the involvement of eCBs in the runner's high in humans has not yet been achieved due to methodological hurdles. In this review, we suggest how to advance the study of the influence of eCBs on the beneficial effects of exercise and provide recommendations on how endocannabinoid release is most likely to occur under laboratory conditions.
The paper
Citation
Siebers M, Biedermann SV, Fuss J Do Endocannabinoids Cause the Runner’s High? Evidence and Open Questions. The Neuroscientist (2023). PubMed 35081831 · DOI
Limitations the authors noted
High heterogeneity in exercise protocols, blood sampling timing, and processing methods across included studies. Small sample sizes in several primary studies resulting in potential underpowering for certain eCB metabolites like 2-AG. Lack of standardized definitions and questionnaires for capturing the 'runner's high'.
In practice
Why this matters
This review clarifies that current evidence does not yet support using endocannabinoid levels as a reliable explanation for exercise-induced euphoria in humans.
Browse related research
Condition: Animal physical conditioning Condition: Emotions Condition: Running Topic: Endocannabinoids
Related on CED Clinic
Back to Daily Research and Patient Questions
Reviewed by Dr. Caplan on September 23, 2026.
This page is general education about a published study. It is not medical advice and does not create a doctor-patient relationship. For care specific to you, book a consultation.